Pharmaceutical News

RSS

California governor’s big promises on drug prices are slow to materialize

When Gov. Gavin Newsom took office in 2019, he promised to lower prescription drug costs for all Californians.

4 Mar 2022

Incidence and outcomes of breakthrough SARS-CoV-2 infections in vaccinated chronic liver disease patients

A new study assesses breakthrough SARS-CoV-2 infections in vaccinated CLD patients with cirrhosis as compared to CLD patients without cirrhosis.

3 Mar 2022

WHO experts suggest antiviral drug for patients with non-severe covid-19 at highest risk of hospitalization

The antiviral drug molnupiravir is conditionally recommended for patients with non-severe covid-19 who are at highest risk of hospitalization, says a WHO Guideline Development Group of international experts in The BMJ today.

3 Mar 2022

Ziath sample management innovation at Analytica 2022

Ziath has chosen Analytica 2022 in Munich, Germany (21-24th June) to launch two new innovative sample management products - Handheld 3 and LUX.

From Ziath Ltd 3 Mar 2022

Short-term change of depressive and anxiety symptoms in relation to COVID-19 vaccination

Researchers assess the short-term impacts of vaccination on the mental health of Swedish adults, with a primary focus on depression and anxiety.

2 Mar 2022

Study finds booster shot did produce effective levels of neutralizing antibodies against omicron

A new study using serum from human blood samples suggests neutralizing antibody levels produced by two-dose mRNA vaccines against the original and early variants of the SARS-CoV-2 virus wane substantially over time, and offer essentially no protection against the omicron variant.

2 Mar 2022

Breakthrough SARS-CoV-2 infection peaks at 5 months

A new study describes the incidence of breakthrough infection with SARS-CoV-2 after vaccination with one of the nucleic acid or viral vector vaccines.

28 Feb 2022

Updated guideline released for managing antirheumatic drugs in patients undergoing hip or knee replacement

The American College of Rheumatology and the American Association of Hip and Knee Surgeons released a summary of their updated guideline for the Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.

28 Feb 2022

Outpatient antibiotic treatment for infective endocarditis improves outcomes, reduces costs

A new modeling study suggests that when patients who inject opioids continue an antibiotic treatment for infective endocarditis outside of the hospital, they experienced better long-term health outcomes than patients who receive the standard four to six weeks of inpatient, intravenous antibiotic therapy.

28 Feb 2022

Computer model warns about the negative consequences of diabetes treatment for some cancers

Using computer drug simulations, researchers have found that doctors need to be wary of prescribing a particular treatment for all types of cancer and patients.

28 Feb 2022

Antibiotics provide no benefit in preventing recurrent wheezing in infants hospitalized with RSV

Antibiotics provide no benefit in preventing future recurrent wheezing in babies hospitalized with respiratory syncytial virus (RSV), according to a new study led by Washington University School of Medicine in St. Louis. And there is some evidence that antibiotics may make wheezing worse.

27 Feb 2022

Study determines effectiveness of COVID-19 vaccination against Omicron variant in high-risk indoor settings

A new study estimates vaccine effectiveness against SARS-CoV-2 Omicron variant in indoor entertainment settings in Australia.

27 Feb 2022

A promising new vaccine for SARS-CoV-2 and influenza

Researchers create a vaccine candidate that could protect against both SARS-CoV-2 and IAVs.

27 Feb 2022

Traditional Chinese medicine can be an effective radiosensitizer for patients with nasopharyngeal carcinoma

Treatment of nasopharyngeal carcinoma (NPC), a group of cancers that originate in the nose and throat, is made complicated by their unique position. Radiation therapy is often the main curative treatment for NPC. However, some patients are resistant to radiation therapy.

25 Feb 2022

Serological responses to heterologous COVID-19 mRNA vaccination in older individuals

Researchers assess the serological response to a real-world COVID-19 vaccination strategy in older individuals who resided in long-term care facilities.

24 Feb 2022

A comparison of COVID-19 vaccines by neutralizing antibody potency

Researchers use an international standardized assessment method to compare the efficacy of antibody responses to the major COVID-19 vaccines.

24 Feb 2022

Study examines the effect of sevoflurane on sleep disturbance caused by systemic inflammation

Getting a good night's sleep can sometimes be a challenge, but inflammation may make it even more difficult.

24 Feb 2022

Nearly 1% of all US adults prescribed opioids are also taking various other sedatives

As many as 2.6 million Americans—equivalent to 1 per cent of all US adults —prescribed opioids are also taking various other sedatives, including benzodiazepines plus another type of sedative drug, estimates research published online in the journal Regional Anesthesia & Pain Medicine.

23 Feb 2022

Omicron neutralizing titers after third BNT162b2 dose are persistent

The new study, published in the journal Cell Host and Microbe, also finds that the neutralization against Omicron remains robust at four months after the third dose of the BNT162b2 vaccine.

22 Feb 2022

Study shows Pfizer-BioNTech booster protects over 65s against Delta and Omicron

New research in nursing home residents found that a third dose of the Pfizer-BioNTech COVID-19 vaccine was effective for at least three months in protecting against the Delta and Omicron variant. While two doses of an mRNA COVID-19 vaccine showed poor neutralization to Omicron than Delta, a booster shot increased neutralizing antibody responses.

22 Feb 2022

Pharmaceutical News

California governor’s big promises on drug prices are slow to materialize

Incidence and outcomes of breakthrough SARS-CoV-2 infections in vaccinated chronic liver disease patients

WHO experts suggest antiviral drug for patients with non-severe covid-19 at highest risk of hospitalization

Ziath sample management innovation at Analytica 2022

Short-term change of depressive and anxiety symptoms in relation to COVID-19 vaccination

Study finds booster shot did produce effective levels of neutralizing antibodies against omicron

Breakthrough SARS-CoV-2 infection peaks at 5 months

Updated guideline released for managing antirheumatic drugs in patients undergoing hip or knee replacement

Outpatient antibiotic treatment for infective endocarditis improves outcomes, reduces costs

Computer model warns about the negative consequences of diabetes treatment for some cancers

Antibiotics provide no benefit in preventing recurrent wheezing in infants hospitalized with RSV

Study determines effectiveness of COVID-19 vaccination against Omicron variant in high-risk indoor settings

A promising new vaccine for SARS-CoV-2 and influenza

Traditional Chinese medicine can be an effective radiosensitizer for patients with nasopharyngeal carcinoma

Serological responses to heterologous COVID-19 mRNA vaccination in older individuals

A comparison of COVID-19 vaccines by neutralizing antibody potency

Study examines the effect of sevoflurane on sleep disturbance caused by systemic inflammation

Nearly 1% of all US adults prescribed opioids are also taking various other sedatives

Omicron neutralizing titers after third BNT162b2 dose are persistent

Study shows Pfizer-BioNTech booster protects over 65s against Delta and Omicron

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News